Photys
Photys Therapeutics | Control of protein post-translational modifications
Waltham, United States · $75.0M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- photys.com
- Total Funding
- $75.0M
- Last Round
- $75.0M Series ASep 2022
- Rounds
- 1
About
Biotech company developing chimeric small molecules for precise protein function control, targeting oncology and autoimmune diseases.
Summary
Photys is a Biotech company based in Waltham, United States. It has raised $75.0M in total across 1 round, most recently a $75.0M Series A round in Sep 2022. Investors include MPM Capital, Omega Funds and Longwood Fund.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2022
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/photys"><img src="https://indexed.vc/api/badge/company/photys" alt="Photys on Indexed.vc" width="260" height="76" /></a>